TB

Thierry Boon-Falleur

LR Ludwig Institute For Cancer Research: 8 patents #1 of 95Top 2%
UL Universite De Liege: 1 patents #2 of 10Top 20%
📍 Brussels, BE: #2 of 94 inventorsTop 3%
Overall (2003): #2,641 of 273,478Top 1%
8
Patents 2003

Issued Patents 2003

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
6669946 METHOD FOR IDENTIFYING INDIVIDUALS SUFFERING FROM A CELLULAR ABNORMALITY SOME OF WHOSE ABNORMAL CELLS PRESENT COMPLEXES OF HUMAN LEUKOCYTE ANTIGEN TYROSINASE DERIVED PEPTIDES, AND METHODS FOR TREATING SAID INDIVIDUALS Vincent Brichard, Aline Van Pel, Etienne De Plaen, Pierre Coulie, Jean-Christope Renauld +2 more 2003-12-30
6667037 Isolated peptides which bind to HLA-B35 molecules, larger peptides which contain these, nucleic acid molecules encoding peptides, and uses thereof Annie Ooms, Gérard De Giiovanni, Sandra Morel, Benoit Van den Eynde 2003-12-23
6638512 Method for treating subjects by using BAGE tumor rejection antigen precursors or tumor rejection antigens Pascale Bo{haeck over (e)}l, Claude Wildmann, Pierre van der Bruggen, Pierre Coulie, Jean-Christophe Renauld 2003-10-28
6602506 Delivery of proteins into eukaryotic cells with recombinant Yersinia Pierre van der Bruggen, Guy R. Cornelis, Anne M. Boland 2003-08-05
6599699 Methods for diagnosing a disorder by assaying for MAGE-3 Béatrice Guagler, Benoit Van den Eynde, Pierre van den Bruggen 2003-07-29
6565857 Methods for treating a disorder by using Mage-3 or Mage-3 related materials Benoit Van den Eynde, Pierre van den Bruggen 2003-05-20
6552180 Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-2 and uses thereof Béatrice Guagler, Benoit Van den Eynde, Pierre van den Bruggen 2003-04-22
6509172 Isolated, truncated nucleic acid which are members of the gage, and uses thereof Olivier De Backer, Benoit Van den Eynde 2003-01-21